Global Post Herpetic Neuralgia Therapies Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
LPI (LP Information)' newest research report, the “Post Herpetic Neuralgia Therapies Industry Forecast” looks at past sales and reviews total world Post Herpetic Neuralgia Therapies sales in 2022, providing a comprehensive analysis by region and market sector of projected Post Herpetic Neuralgia Therapies sales for 2023 through 2029. With Post Herpetic Neuralgia Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Post Herpetic Neuralgia Therapies industry.
This Insight Report provides a comprehensive analysis of the global Post Herpetic Neuralgia Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Post Herpetic Neuralgia Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Post Herpetic Neuralgia Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Post Herpetic Neuralgia Therapies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Post Herpetic Neuralgia Therapies.
The global Post Herpetic Neuralgia Therapies market size is projected to grow from US$ 1551.5 million in 2022 to US$ 2050.8 million in 2029; it is expected to grow at a CAGR of 4.1% from 2023 to 2029.
United States market for Post Herpetic Neuralgia Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Post Herpetic Neuralgia Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Post Herpetic Neuralgia Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Post Herpetic Neuralgia Therapies players cover Endo Pharmaceuticals, Depomed, Acorda Therapeutics, Pfizer, Mylan, Daiichi Sankyo and Teikoku Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Post Herpetic Neuralgia Therapies market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Post herpetic neuralgia is a painful condition that can occur after having shingles, a complication of chicken pox. The goal of therapy for postherpetic neuralgia is to reduce morbidity through the use of tricyclic antidepressants, anticonvulsants, anesthetics, analgesics, corticosteroids and antiviral agents.
LPI (LP Information)' newest research report, the “Post Herpetic Neuralgia Therapies Industry Forecast” looks at past sales and reviews total world Post Herpetic Neuralgia Therapies sales in 2022, providing a comprehensive analysis by region and market sector of projected Post Herpetic Neuralgia Therapies sales for 2023 through 2029. With Post Herpetic Neuralgia Therapies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Post Herpetic Neuralgia Therapies industry.
This Insight Report provides a comprehensive analysis of the global Post Herpetic Neuralgia Therapies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Post Herpetic Neuralgia Therapies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Post Herpetic Neuralgia Therapies market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Post Herpetic Neuralgia Therapies and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Post Herpetic Neuralgia Therapies.
The global Post Herpetic Neuralgia Therapies market size is projected to grow from US$ 1551.5 million in 2022 to US$ 2050.8 million in 2029; it is expected to grow at a CAGR of 4.1% from 2023 to 2029.
United States market for Post Herpetic Neuralgia Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Post Herpetic Neuralgia Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Post Herpetic Neuralgia Therapies is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Post Herpetic Neuralgia Therapies players cover Endo Pharmaceuticals, Depomed, Acorda Therapeutics, Pfizer, Mylan, Daiichi Sankyo and Teikoku Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Post Herpetic Neuralgia Therapies market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Drugs
- Patches
- Steroid Injectable
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Endo Pharmaceuticals
- Depomed
- Acorda Therapeutics
- Pfizer
- Mylan
- Daiichi Sankyo
- Teikoku Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Post Herpetic Neuralgia Therapies Market Size 2018-2029
2.1.2 Post Herpetic Neuralgia Therapies Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Post Herpetic Neuralgia Therapies Segment by Type
2.2.1 Drugs
2.2.2 Patches
2.2.3 Steroid Injectable
2.3 Post Herpetic Neuralgia Therapies Market Size by Type
2.3.1 Post Herpetic Neuralgia Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
2.4 Post Herpetic Neuralgia Therapies Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Post Herpetic Neuralgia Therapies Market Size by Application
2.5.1 Post Herpetic Neuralgia Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
3 POST HERPETIC NEURALGIA THERAPIES MARKET SIZE BY PLAYER
3.1 Post Herpetic Neuralgia Therapies Market Size Market Share by Players
3.1.1 Global Post Herpetic Neuralgia Therapies Revenue by Players (2018-2023)
3.1.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Post Herpetic Neuralgia Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 POST HERPETIC NEURALGIA THERAPIES BY REGIONS
4.1 Post Herpetic Neuralgia Therapies Market Size by Regions (2018-2023)
4.2 Americas Post Herpetic Neuralgia Therapies Market Size Growth (2018-2023)
4.3 APAC Post Herpetic Neuralgia Therapies Market Size Growth (2018-2023)
4.4 Europe Post Herpetic Neuralgia Therapies Market Size Growth (2018-2023)
4.5 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Post Herpetic Neuralgia Therapies Market Size by Country (2018-2023)
5.2 Americas Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023)
5.3 Americas Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Post Herpetic Neuralgia Therapies Market Size by Region (2018-2023)
6.2 APAC Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023)
6.3 APAC Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Post Herpetic Neuralgia Therapies by Country (2018-2023)
7.2 Europe Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023)
7.3 Europe Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Post Herpetic Neuralgia Therapies by Region (2018-2023)
8.2 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023)
8.3 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL POST HERPETIC NEURALGIA THERAPIES MARKET FORECAST
10.1 Global Post Herpetic Neuralgia Therapies Forecast by Regions (2024-2029)
10.1.1 Global Post Herpetic Neuralgia Therapies Forecast by Regions (2024-2029)
10.1.2 Americas Post Herpetic Neuralgia Therapies Forecast
10.1.3 APAC Post Herpetic Neuralgia Therapies Forecast
10.1.4 Europe Post Herpetic Neuralgia Therapies Forecast
10.1.5 Middle East & Africa Post Herpetic Neuralgia Therapies Forecast
10.2 Americas Post Herpetic Neuralgia Therapies Forecast by Country (2024-2029)
10.2.1 United States Post Herpetic Neuralgia Therapies Market Forecast
10.2.2 Canada Post Herpetic Neuralgia Therapies Market Forecast
10.2.3 Mexico Post Herpetic Neuralgia Therapies Market Forecast
10.2.4 Brazil Post Herpetic Neuralgia Therapies Market Forecast
10.3 APAC Post Herpetic Neuralgia Therapies Forecast by Region (2024-2029)
10.3.1 China Post Herpetic Neuralgia Therapies Market Forecast
10.3.2 Japan Post Herpetic Neuralgia Therapies Market Forecast
10.3.3 Korea Post Herpetic Neuralgia Therapies Market Forecast
10.3.4 Southeast Asia Post Herpetic Neuralgia Therapies Market Forecast
10.3.5 India Post Herpetic Neuralgia Therapies Market Forecast
10.3.6 Australia Post Herpetic Neuralgia Therapies Market Forecast
10.4 Europe Post Herpetic Neuralgia Therapies Forecast by Country (2024-2029)
10.4.1 Germany Post Herpetic Neuralgia Therapies Market Forecast
10.4.2 France Post Herpetic Neuralgia Therapies Market Forecast
10.4.3 UK Post Herpetic Neuralgia Therapies Market Forecast
10.4.4 Italy Post Herpetic Neuralgia Therapies Market Forecast
10.4.5 Russia Post Herpetic Neuralgia Therapies Market Forecast
10.5 Middle East & Africa Post Herpetic Neuralgia Therapies Forecast by Region (2024-2029)
10.5.1 Egypt Post Herpetic Neuralgia Therapies Market Forecast
10.5.2 South Africa Post Herpetic Neuralgia Therapies Market Forecast
10.5.3 Israel Post Herpetic Neuralgia Therapies Market Forecast
10.5.4 Turkey Post Herpetic Neuralgia Therapies Market Forecast
10.5.5 GCC Countries Post Herpetic Neuralgia Therapies Market Forecast
10.6 Global Post Herpetic Neuralgia Therapies Forecast by Type (2024-2029)
10.7 Global Post Herpetic Neuralgia Therapies Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Endo Pharmaceuticals
11.1.1 Endo Pharmaceuticals Company Information
11.1.2 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product Offered
11.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Endo Pharmaceuticals Main Business Overview
11.1.5 Endo Pharmaceuticals Latest Developments
11.2 Depomed
11.2.1 Depomed Company Information
11.2.2 Depomed Post Herpetic Neuralgia Therapies Product Offered
11.2.3 Depomed Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Depomed Main Business Overview
11.2.5 Depomed Latest Developments
11.3 Acorda Therapeutics
11.3.1 Acorda Therapeutics Company Information
11.3.2 Acorda Therapeutics Post Herpetic Neuralgia Therapies Product Offered
11.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Acorda Therapeutics Main Business Overview
11.3.5 Acorda Therapeutics Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Post Herpetic Neuralgia Therapies Product Offered
11.4.3 Pfizer Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Mylan
11.5.1 Mylan Company Information
11.5.2 Mylan Post Herpetic Neuralgia Therapies Product Offered
11.5.3 Mylan Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Mylan Main Business Overview
11.5.5 Mylan Latest Developments
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Information
11.6.2 Daiichi Sankyo Post Herpetic Neuralgia Therapies Product Offered
11.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Daiichi Sankyo Main Business Overview
11.6.5 Daiichi Sankyo Latest Developments
11.7 Teikoku Pharma
11.7.1 Teikoku Pharma Company Information
11.7.2 Teikoku Pharma Post Herpetic Neuralgia Therapies Product Offered
11.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Teikoku Pharma Main Business Overview
11.7.5 Teikoku Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Post Herpetic Neuralgia Therapies Market Size 2018-2029
2.1.2 Post Herpetic Neuralgia Therapies Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Post Herpetic Neuralgia Therapies Segment by Type
2.2.1 Drugs
2.2.2 Patches
2.2.3 Steroid Injectable
2.3 Post Herpetic Neuralgia Therapies Market Size by Type
2.3.1 Post Herpetic Neuralgia Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
2.4 Post Herpetic Neuralgia Therapies Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Online Pharmacies
2.4.3 Retail Pharmacies
2.5 Post Herpetic Neuralgia Therapies Market Size by Application
2.5.1 Post Herpetic Neuralgia Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
3 POST HERPETIC NEURALGIA THERAPIES MARKET SIZE BY PLAYER
3.1 Post Herpetic Neuralgia Therapies Market Size Market Share by Players
3.1.1 Global Post Herpetic Neuralgia Therapies Revenue by Players (2018-2023)
3.1.2 Global Post Herpetic Neuralgia Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Post Herpetic Neuralgia Therapies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 POST HERPETIC NEURALGIA THERAPIES BY REGIONS
4.1 Post Herpetic Neuralgia Therapies Market Size by Regions (2018-2023)
4.2 Americas Post Herpetic Neuralgia Therapies Market Size Growth (2018-2023)
4.3 APAC Post Herpetic Neuralgia Therapies Market Size Growth (2018-2023)
4.4 Europe Post Herpetic Neuralgia Therapies Market Size Growth (2018-2023)
4.5 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Post Herpetic Neuralgia Therapies Market Size by Country (2018-2023)
5.2 Americas Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023)
5.3 Americas Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Post Herpetic Neuralgia Therapies Market Size by Region (2018-2023)
6.2 APAC Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023)
6.3 APAC Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Post Herpetic Neuralgia Therapies by Country (2018-2023)
7.2 Europe Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023)
7.3 Europe Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Post Herpetic Neuralgia Therapies by Region (2018-2023)
8.2 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023)
8.3 Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL POST HERPETIC NEURALGIA THERAPIES MARKET FORECAST
10.1 Global Post Herpetic Neuralgia Therapies Forecast by Regions (2024-2029)
10.1.1 Global Post Herpetic Neuralgia Therapies Forecast by Regions (2024-2029)
10.1.2 Americas Post Herpetic Neuralgia Therapies Forecast
10.1.3 APAC Post Herpetic Neuralgia Therapies Forecast
10.1.4 Europe Post Herpetic Neuralgia Therapies Forecast
10.1.5 Middle East & Africa Post Herpetic Neuralgia Therapies Forecast
10.2 Americas Post Herpetic Neuralgia Therapies Forecast by Country (2024-2029)
10.2.1 United States Post Herpetic Neuralgia Therapies Market Forecast
10.2.2 Canada Post Herpetic Neuralgia Therapies Market Forecast
10.2.3 Mexico Post Herpetic Neuralgia Therapies Market Forecast
10.2.4 Brazil Post Herpetic Neuralgia Therapies Market Forecast
10.3 APAC Post Herpetic Neuralgia Therapies Forecast by Region (2024-2029)
10.3.1 China Post Herpetic Neuralgia Therapies Market Forecast
10.3.2 Japan Post Herpetic Neuralgia Therapies Market Forecast
10.3.3 Korea Post Herpetic Neuralgia Therapies Market Forecast
10.3.4 Southeast Asia Post Herpetic Neuralgia Therapies Market Forecast
10.3.5 India Post Herpetic Neuralgia Therapies Market Forecast
10.3.6 Australia Post Herpetic Neuralgia Therapies Market Forecast
10.4 Europe Post Herpetic Neuralgia Therapies Forecast by Country (2024-2029)
10.4.1 Germany Post Herpetic Neuralgia Therapies Market Forecast
10.4.2 France Post Herpetic Neuralgia Therapies Market Forecast
10.4.3 UK Post Herpetic Neuralgia Therapies Market Forecast
10.4.4 Italy Post Herpetic Neuralgia Therapies Market Forecast
10.4.5 Russia Post Herpetic Neuralgia Therapies Market Forecast
10.5 Middle East & Africa Post Herpetic Neuralgia Therapies Forecast by Region (2024-2029)
10.5.1 Egypt Post Herpetic Neuralgia Therapies Market Forecast
10.5.2 South Africa Post Herpetic Neuralgia Therapies Market Forecast
10.5.3 Israel Post Herpetic Neuralgia Therapies Market Forecast
10.5.4 Turkey Post Herpetic Neuralgia Therapies Market Forecast
10.5.5 GCC Countries Post Herpetic Neuralgia Therapies Market Forecast
10.6 Global Post Herpetic Neuralgia Therapies Forecast by Type (2024-2029)
10.7 Global Post Herpetic Neuralgia Therapies Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Endo Pharmaceuticals
11.1.1 Endo Pharmaceuticals Company Information
11.1.2 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product Offered
11.1.3 Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Endo Pharmaceuticals Main Business Overview
11.1.5 Endo Pharmaceuticals Latest Developments
11.2 Depomed
11.2.1 Depomed Company Information
11.2.2 Depomed Post Herpetic Neuralgia Therapies Product Offered
11.2.3 Depomed Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Depomed Main Business Overview
11.2.5 Depomed Latest Developments
11.3 Acorda Therapeutics
11.3.1 Acorda Therapeutics Company Information
11.3.2 Acorda Therapeutics Post Herpetic Neuralgia Therapies Product Offered
11.3.3 Acorda Therapeutics Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Acorda Therapeutics Main Business Overview
11.3.5 Acorda Therapeutics Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Post Herpetic Neuralgia Therapies Product Offered
11.4.3 Pfizer Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Mylan
11.5.1 Mylan Company Information
11.5.2 Mylan Post Herpetic Neuralgia Therapies Product Offered
11.5.3 Mylan Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Mylan Main Business Overview
11.5.5 Mylan Latest Developments
11.6 Daiichi Sankyo
11.6.1 Daiichi Sankyo Company Information
11.6.2 Daiichi Sankyo Post Herpetic Neuralgia Therapies Product Offered
11.6.3 Daiichi Sankyo Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Daiichi Sankyo Main Business Overview
11.6.5 Daiichi Sankyo Latest Developments
11.7 Teikoku Pharma
11.7.1 Teikoku Pharma Company Information
11.7.2 Teikoku Pharma Post Herpetic Neuralgia Therapies Product Offered
11.7.3 Teikoku Pharma Post Herpetic Neuralgia Therapies Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Teikoku Pharma Main Business Overview
11.7.5 Teikoku Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Post Herpetic Neuralgia Therapies Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Drugs
Table 3. Major Players of Patches
Table 4. Major Players of Steroid Injectable
Table 5. Post Herpetic Neuralgia Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Table 8. Post Herpetic Neuralgia Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Table 11. Global Post Herpetic Neuralgia Therapies Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Player (2018-2023)
Table 13. Post Herpetic Neuralgia Therapies Key Players Head office and Products Offered
Table 14. Post Herpetic Neuralgia Therapies Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Post Herpetic Neuralgia Therapies Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Regions (2018-2023)
Table 19. Global Post Herpetic Neuralgia Therapies Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Post Herpetic Neuralgia Therapies Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Post Herpetic Neuralgia Therapies Market Size Market Share by Country (2018-2023)
Table 23. Americas Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Table 25. Americas Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Table 27. APAC Post Herpetic Neuralgia Therapies Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Region (2018-2023)
Table 29. APAC Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Table 31. APAC Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Table 33. Europe Post Herpetic Neuralgia Therapies Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Country (2018-2023)
Table 35. Europe Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Table 37. Europe Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Post Herpetic Neuralgia Therapies
Table 46. Key Market Challenges & Risks of Post Herpetic Neuralgia Therapies
Table 47. Key Industry Trends of Post Herpetic Neuralgia Therapies
Table 48. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Post Herpetic Neuralgia Therapies Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Endo Pharmaceuticals Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 53. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product Offered
Table 54. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Endo Pharmaceuticals Main Business
Table 56. Endo Pharmaceuticals Latest Developments
Table 57. Depomed Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 58. Depomed Post Herpetic Neuralgia Therapies Product Offered
Table 59. Depomed Main Business
Table 60. Depomed Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Depomed Latest Developments
Table 62. Acorda Therapeutics Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 63. Acorda Therapeutics Post Herpetic Neuralgia Therapies Product Offered
Table 64. Acorda Therapeutics Main Business
Table 65. Acorda Therapeutics Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Acorda Therapeutics Latest Developments
Table 67. Pfizer Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 68. Pfizer Post Herpetic Neuralgia Therapies Product Offered
Table 69. Pfizer Main Business
Table 70. Pfizer Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer Latest Developments
Table 72. Mylan Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 73. Mylan Post Herpetic Neuralgia Therapies Product Offered
Table 74. Mylan Main Business
Table 75. Mylan Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Mylan Latest Developments
Table 77. Daiichi Sankyo Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 78. Daiichi Sankyo Post Herpetic Neuralgia Therapies Product Offered
Table 79. Daiichi Sankyo Main Business
Table 80. Daiichi Sankyo Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Daiichi Sankyo Latest Developments
Table 82. Teikoku Pharma Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 83. Teikoku Pharma Post Herpetic Neuralgia Therapies Product Offered
Table 84. Teikoku Pharma Main Business
Table 85. Teikoku Pharma Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Teikoku Pharma Latest Developments
Table 1. Post Herpetic Neuralgia Therapies Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Drugs
Table 3. Major Players of Patches
Table 4. Major Players of Steroid Injectable
Table 5. Post Herpetic Neuralgia Therapies Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Table 8. Post Herpetic Neuralgia Therapies Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Table 11. Global Post Herpetic Neuralgia Therapies Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Player (2018-2023)
Table 13. Post Herpetic Neuralgia Therapies Key Players Head office and Products Offered
Table 14. Post Herpetic Neuralgia Therapies Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Post Herpetic Neuralgia Therapies Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Regions (2018-2023)
Table 19. Global Post Herpetic Neuralgia Therapies Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Post Herpetic Neuralgia Therapies Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Post Herpetic Neuralgia Therapies Market Size Market Share by Country (2018-2023)
Table 23. Americas Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Table 25. Americas Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Table 27. APAC Post Herpetic Neuralgia Therapies Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Region (2018-2023)
Table 29. APAC Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Table 31. APAC Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Table 33. Europe Post Herpetic Neuralgia Therapies Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Country (2018-2023)
Table 35. Europe Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Table 37. Europe Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Post Herpetic Neuralgia Therapies
Table 46. Key Market Challenges & Risks of Post Herpetic Neuralgia Therapies
Table 47. Key Industry Trends of Post Herpetic Neuralgia Therapies
Table 48. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Post Herpetic Neuralgia Therapies Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Post Herpetic Neuralgia Therapies Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Endo Pharmaceuticals Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 53. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Product Offered
Table 54. Endo Pharmaceuticals Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Endo Pharmaceuticals Main Business
Table 56. Endo Pharmaceuticals Latest Developments
Table 57. Depomed Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 58. Depomed Post Herpetic Neuralgia Therapies Product Offered
Table 59. Depomed Main Business
Table 60. Depomed Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Depomed Latest Developments
Table 62. Acorda Therapeutics Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 63. Acorda Therapeutics Post Herpetic Neuralgia Therapies Product Offered
Table 64. Acorda Therapeutics Main Business
Table 65. Acorda Therapeutics Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Acorda Therapeutics Latest Developments
Table 67. Pfizer Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 68. Pfizer Post Herpetic Neuralgia Therapies Product Offered
Table 69. Pfizer Main Business
Table 70. Pfizer Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Pfizer Latest Developments
Table 72. Mylan Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 73. Mylan Post Herpetic Neuralgia Therapies Product Offered
Table 74. Mylan Main Business
Table 75. Mylan Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Mylan Latest Developments
Table 77. Daiichi Sankyo Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 78. Daiichi Sankyo Post Herpetic Neuralgia Therapies Product Offered
Table 79. Daiichi Sankyo Main Business
Table 80. Daiichi Sankyo Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Daiichi Sankyo Latest Developments
Table 82. Teikoku Pharma Details, Company Type, Post Herpetic Neuralgia Therapies Area Served and Its Competitors
Table 83. Teikoku Pharma Post Herpetic Neuralgia Therapies Product Offered
Table 84. Teikoku Pharma Main Business
Table 85. Teikoku Pharma Post Herpetic Neuralgia Therapies Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. Teikoku Pharma Latest Developments
LIST OF FIGURES
Figure 1. Post Herpetic Neuralgia Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Post Herpetic Neuralgia Therapies Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Post Herpetic Neuralgia Therapies Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Post Herpetic Neuralgia Therapies Sales Market Share by Country/Region (2022)
Figure 8. Post Herpetic Neuralgia Therapies Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Type in 2022
Figure 10. Post Herpetic Neuralgia Therapies in Hospital Pharmacies
Figure 11. Global Post Herpetic Neuralgia Therapies Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Post Herpetic Neuralgia Therapies in Online Pharmacies
Figure 13. Global Post Herpetic Neuralgia Therapies Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 14. Post Herpetic Neuralgia Therapies in Retail Pharmacies
Figure 15. Global Post Herpetic Neuralgia Therapies Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Application in 2022
Figure 17. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Player in 2022
Figure 18. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Post Herpetic Neuralgia Therapies Market Size 2018-2023 ($ Millions)
Figure 20. APAC Post Herpetic Neuralgia Therapies Market Size 2018-2023 ($ Millions)
Figure 21. Europe Post Herpetic Neuralgia Therapies Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size 2018-2023 ($ Millions)
Figure 23. Americas Post Herpetic Neuralgia Therapies Value Market Share by Country in 2022
Figure 24. United States Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Region in 2022
Figure 29. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Type in 2022
Figure 30. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Application in 2022
Figure 31. China Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Country in 2022
Figure 38. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Figure 39. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Figure 40. Germany Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 54. APAC Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 55. Europe Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 57. United States Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 58. Canada Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 61. China Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 62. Japan Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 63. Korea Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 65. India Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 66. Australia Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 67. Germany Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 68. France Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 69. UK Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 70. Italy Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 71. Russia Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 72. Spain Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 75. Israel Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 78. Global Post Herpetic Neuralgia Therapies Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Post Herpetic Neuralgia Therapies Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Post Herpetic Neuralgia Therapies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Post Herpetic Neuralgia Therapies Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Post Herpetic Neuralgia Therapies Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Post Herpetic Neuralgia Therapies Sales Market Share by Country/Region (2022)
Figure 8. Post Herpetic Neuralgia Therapies Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Type in 2022
Figure 10. Post Herpetic Neuralgia Therapies in Hospital Pharmacies
Figure 11. Global Post Herpetic Neuralgia Therapies Market: Hospital Pharmacies (2018-2023) & ($ Millions)
Figure 12. Post Herpetic Neuralgia Therapies in Online Pharmacies
Figure 13. Global Post Herpetic Neuralgia Therapies Market: Online Pharmacies (2018-2023) & ($ Millions)
Figure 14. Post Herpetic Neuralgia Therapies in Retail Pharmacies
Figure 15. Global Post Herpetic Neuralgia Therapies Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 16. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Application in 2022
Figure 17. Global Post Herpetic Neuralgia Therapies Revenue Market Share by Player in 2022
Figure 18. Global Post Herpetic Neuralgia Therapies Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Post Herpetic Neuralgia Therapies Market Size 2018-2023 ($ Millions)
Figure 20. APAC Post Herpetic Neuralgia Therapies Market Size 2018-2023 ($ Millions)
Figure 21. Europe Post Herpetic Neuralgia Therapies Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size 2018-2023 ($ Millions)
Figure 23. Americas Post Herpetic Neuralgia Therapies Value Market Share by Country in 2022
Figure 24. United States Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Region in 2022
Figure 29. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Type in 2022
Figure 30. APAC Post Herpetic Neuralgia Therapies Market Size Market Share by Application in 2022
Figure 31. China Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Country in 2022
Figure 38. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Figure 39. Europe Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Figure 40. Germany Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Post Herpetic Neuralgia Therapies Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 54. APAC Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 55. Europe Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 57. United States Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 58. Canada Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 61. China Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 62. Japan Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 63. Korea Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 65. India Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 66. Australia Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 67. Germany Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 68. France Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 69. UK Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 70. Italy Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 71. Russia Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 72. Spain Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 75. Israel Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Post Herpetic Neuralgia Therapies Market Size 2024-2029 ($ Millions)
Figure 78. Global Post Herpetic Neuralgia Therapies Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Post Herpetic Neuralgia Therapies Market Size Market Share Forecast by Application (2024-2029)
